150 related articles for article (PubMed ID: 31503380)
21. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium.
Wilkey JF; Buchberger G; Saucier K; Patel SM; Eisenberg E; Nakagawa H; Michaylira CZ; Rustgi AK; Mallya SM
Mol Carcinog; 2009 Sep; 48(9):853-61. PubMed ID: 19263437
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Significance of Cyclins A2, B1, D1, and E1 and
Monteiro LS; Diniz-Freitas M; Warnakulasuriya S; Garcia-Caballero T; Forteza-Vila J; Fraga M
Anal Cell Pathol (Amst); 2018; 2018():7253510. PubMed ID: 29785357
[TBL] [Abstract][Full Text] [Related]
24. Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas.
Gillard M; Cadieu E; De Brito C; Abadie J; Vergier B; Devauchelle P; Degorce F; Dréano S; Primot A; Dorso L; Lagadic M; Galibert F; Hédan B; Galibert MD; André C
Pigment Cell Melanoma Res; 2014 Jan; 27(1):90-102. PubMed ID: 24112648
[TBL] [Abstract][Full Text] [Related]
25. PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis.
Iussich S; Maniscalco L; Di Sciuva A; Iotti B; Morello E; Martano M; Gattino F; Buracco P; De Maria R
Vet Comp Oncol; 2017 Jun; 15(2):462-469. PubMed ID: 26833575
[TBL] [Abstract][Full Text] [Related]
26. Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias.
Rousseau A; Lim MS; Lin Z; Jordan RC
Oral Oncol; 2001 Apr; 37(3):268-75. PubMed ID: 11287281
[TBL] [Abstract][Full Text] [Related]
27. An update on the implications of cyclin D1 in melanomas.
González-Ruiz L; González-Moles MÁ; González-Ruiz I; Ruiz-Ávila I; Ayén Á; Ramos-García P
Pigment Cell Melanoma Res; 2020 Nov; 33(6):788-805. PubMed ID: 32147907
[TBL] [Abstract][Full Text] [Related]
28. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
[TBL] [Abstract][Full Text] [Related]
29. Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.
Shelly S; Chien MB; Yip B; Kent MS; Theon AP; McCallan JL; London CA
Mamm Genome; 2005 Mar; 16(3):211-7. PubMed ID: 15834638
[TBL] [Abstract][Full Text] [Related]
30. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of tenascin in melanocytic tumours of dogs.
Sevastre B; van Ederen AM; Terlou M; Gruys E; Nederbragt H
J Comp Pathol; 2007 Jan; 136(1):49-56. PubMed ID: 17258226
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas.
Miyamoto R; Uzawa N; Nagaoka S; Hirata Y; Amagasa T
Oral Oncol; 2003 Sep; 39(6):610-8. PubMed ID: 12798405
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.
Finotello R; Monné Rodriguez JM; Vilafranca M; Altimira J; Ramirez GA; Haines A; Ressel L
Vet Comp Oncol; 2017 Dec; 15(4):1393-1402. PubMed ID: 27779366
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
35. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.
Krsková L; Kalinová M; Brízová H; Mrhalová M; Sumerauer D; Kodet R
Cancer Genet Cytogenet; 2009 Aug; 193(1):1-8. PubMed ID: 19602458
[TBL] [Abstract][Full Text] [Related]
36. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
37. Expression of proliferation genes in formalin-fixed paraffin-embedded (FFPE) tissue from breast carcinomas. Feasibility and relevance for a routine histopathology laboratory.
Thomas C; Robinson C; Dessauvagie B; Wood B; Sterrett G; Harvey J; Amanuel B
J Clin Pathol; 2017 Jan; 70(1):25-32. PubMed ID: 27235535
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1 gene (CCND1) mutations in endometrial cancer.
Moreno-Bueno G; Rodríguez-Perales S; Sánchez-Estévez C; Hardisson D; Sarrió D; Prat J; Cigudosa JC; Matias-Guiu X; Palacios J
Oncogene; 2003 Sep; 22(38):6115-8. PubMed ID: 12955092
[TBL] [Abstract][Full Text] [Related]
39. Asymmetrical proliferative pattern loss linked to cyclin D1 overexpression in adjacent non-tumour epithelium in oral squamous cell carcinoma.
Ramos-García P; González-Moles MÁ; Ayén Á; González-Ruiz L; Ruiz-Ávila I; Lenouvel D; Gil-Montoya JA; Bravo M
Arch Oral Biol; 2019 Jan; 97():12-17. PubMed ID: 30321764
[TBL] [Abstract][Full Text] [Related]
40. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R
Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
